Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Douglas Fambrough Insider Profile
4 Followers
Douglas Fambrough, CEO, Director at Dicerna Pharma, holds 231.43K shares in Dicerna Pharma (Ticker: DRNA), holds ― shares in Oncorus (Ticker: ONCR).
Douglas Fambrough Dicerna Pharma (DRNA)CEO, Director
Dicerna Pharma (DRNA)
CEO, Director
Ranked #78,451 out of 100,202 Corporate Insiders
Profitable Transactions
1 out of 4 Profitable Transactions
Average Return
-22.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Douglas Fambrough does not currently own shares as a corporate insider.
A breakdown of Douglas Fambrough's holdings
Insider Roles
Douglas Fambrough does not currently hold a role as a corporate insider.
Roles that Douglas Fambrough holds in companies
Most Profitable Insider Trade
Stock:
Dicerna Pharma
(DRNA)
(DRNA)
Rating:Informative Buy
Date:Sep 01, 2020 - Sep 01, 2021
Return:+13.70%
The most profitable trade made by Douglas Fambrough
Douglas Fambrough's Trading History
Dicerna Pharma
Aug 10, 2021
―
Uninformative Buy
110.45K
$8.85M
Oncorus
―
―
―
―
List of latest transactions for each holding click on a transaction to see Douglas Fambrough's performance on stock
You May Also Like
Douglas Fambrough insider profile FAQ
What is the percentage of profitable transactions made by Douglas Fambrough?
The percentage of profitable transactions made by Douglas Fambrough is 25%.
What is the average return per transaction made by Douglas Fambrough?
The average return per transaction made by Douglas Fambrough is -22.50%.
What stocks does Douglas Fambrough hold?
Douglas Fambrough holds: DRNA, ONCR stocks.
What was Douglas Fambrough’s latest transaction?
Douglas Fambrough latest transaction was an Uninformative Buy of $110.45K.
What was Douglas Fambrough's most profitable transaction?
Douglas Fambrough’s most profitable transaction was an Informative Buy of DRNA stock on September 1, 2020. The return on the trade was 13.70%.
What is Douglas Fambrough's role in Dicerna Pharma?
Douglas Fambrough's role in Dicerna Pharma is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.